|
|
Stem Cell in Physiology and Drug Discovery
Sponsored by
APS Liaison with Industry
Committee
Translational Physiology Track
Sunday, April 29 — 10:30 AM-12:30 PM
Washington, DC Convention Center — Room 145A
|
| Chaired: |
Chahrzad Montrose-Rafizadeh, Eli Lilly
and Company, Inc.
Brigid Hogan, Duke Univ. |
Research into the isolation and use of
stem cells is accelerating rapidly and has broad application in a
variety of areas. Stem cells hold great promise in research into basic
cell physiology, in studying pathways of cellular differentiation, as
tools in drug discovery, and in regenerative medicine. In this symposium
the invited speakers will present their latest findings in stem cell
research. Dr. Allsopp will review his latest efforts in expanding human
stem cells and in their use in studying basic physiological processes.
Dr. John McNeish will discuss the use of stem cells in target
identification and validation as well as in the drug screening. Dr.
Aaron Chuang will focus on stem cells in neurodegeneration. Finally, Dr.
Betty Yan will give us an insight on Protein C pathway discovery using
human stem cells.
|
10:30 AM |
Stem cells and new medicines: unleashing the potential to realize
the expectation.
Timothy E. Allsopp, Stem
Cell Sciences PLC, Edinburgh, UK
|
|
11:00 AM |
Pharmacology applications for stem cells in drug
discovery.
John McNeish, Pfizer Global Research & Development, Groton,
CT
|
|
11:30 AM |
Manipulating stem cells physiology for neurodegenerative disease
therapy.
Aaron T. Chuang, GlaxoSmith Kline, Essex, UK
|
|
12:00 PM |
Protein C
pathway in human endothelial progenitor cells (EPCs) isolated from
cord blood.
Sau Chi Betty Yan, Eli Lilly and Company, Inc.,
Indianapolis
|
|
|